InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-25.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Russell Angus C., Director. Insider active across 3 companies, notably Revance Therapeutics, Inc.. In total, 13 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €178k. Activity tracked since 5 May 2021. The latest transaction was disclosed on 4 February 2025 (U). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
36,506 shares@ US$3.6542.0% of flowCommon StockSEC:0000950170-25-015322:0
15,000 shares0Common StockSEC:0001479290-24-000089:0
3,534 shares0Common StockSEC:0001479290-23-000060:0
1,984 sharesCommon StockSEC:0001209191-22-046966:0
6,059 shares0Common StockSEC:0001479290-22-000059:0
6,400 shares@ US$15.740850.0% of flowCommon StockSEC:0001479290-21-000173:0
Ideal exit: 9 Sept 2022 (T+270)
6,400 shares@ US$15.7408100.0% of flowCommon StockSEC:0001479290-21-000173
Ideal exit: 9 Sept 2022 (T+270)
96,864 sharesCommon StockSEC:0001387131-21-008440
96,864 sharesCommon StockSEC:0001387131-21-008440:0
24,720 shares@ US$2.2050.0% of flowCommon Shares, no par valueSEC:0001493152-21-015786
24,720 shares@ US$2.200.011% mcap50.0% of flowCommon Shares, no par valueSEC:0001493152-21-015786:0
4,013 shares0Common StockSEC:0001479290-21-000114
4,013 shares0Common StockSEC:0001479290-21-000114:0
13 of 13 declarations
About Russell Angus C.
Angus C. Russell serves as a Board Member at Revance Therapeutics, Inc., Lineage Cell Therapeutics, Inc., and TherapeuticsMD, Inc. He plays a key role in the governance of these companies, bringing his expertise in strategy and sustainability. His commitment to innovation and operational efficiency is essential for the success of the boards.
